It is a strange announcement. First they say they need it for the current trial then they say this.
"Therefore, to supply the large markets Benitec is aiming for such as in hepatitis C and B, the Company is moving to establish its own large-scale manufacturing process in collaboration with third parties, and we will make further announcements about those developments as they occur.”
So are they trying to spin a negative announcement into a positive one by saying on one hand they don't have enough TT-034 to finish the current trial but we need to establish this manufacturing process anyway if TT-034 is successful?
And why are we up 8% if its bad news?
- Forums
- ASX - By Stock
- BLT
- Ann: MANUFACTURING UPDATE
Ann: MANUFACTURING UPDATE, page-11
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online